SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 190 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $7 | -22.2% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $9 | -43.8% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $16 | -99.9% | 5,000 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $25,000 | +19.0% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $21,000 | -27.6% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $29,000 | -23.7% | 5,000 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $38,000 | -15.6% | 5,000 | 0.0% | 0.00% | -25.0% |
| Q3 2021 | $45,000 | -25.0% | 5,000 | 0.0% | 0.00% | -20.0% |
| Q2 2021 | $60,000 | -4.8% | 5,000 | 0.0% | 0.01% | -16.7% |
| Q1 2021 | $63,000 | -19.2% | 5,000 | 0.0% | 0.01% | -14.3% |
| Q4 2020 | $78,000 | +66.0% | 5,000 | 0.0% | 0.01% | +40.0% |
| Q3 2020 | $47,000 | +4.4% | 5,000 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $45,000 | +40.6% | 5,000 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $32,000 | -23.8% | 5,000 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $42,000 | -6.7% | 5,000 | 0.0% | 0.01% | -16.7% |
| Q3 2019 | $45,000 | -16.7% | 5,000 | 0.0% | 0.01% | -14.3% |
| Q2 2019 | $54,000 | +12.5% | 5,000 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $48,000 | -15.8% | 5,000 | 0.0% | 0.01% | -22.2% |
| Q4 2018 | $57,000 | -32.9% | 5,000 | 0.0% | 0.01% | -18.2% |
| Q3 2018 | $85,000 | +19.7% | 5,000 | 0.0% | 0.01% | +10.0% |
| Q2 2018 | $71,000 | -25.3% | 5,000 | 0.0% | 0.01% | -28.6% |
| Q1 2018 | $95,000 | +15.9% | 5,000 | 0.0% | 0.01% | +27.3% |
| Q4 2017 | $82,000 | +9.3% | 5,000 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $75,000 | +70.5% | 5,000 | 0.0% | 0.01% | +57.1% |
| Q2 2017 | $44,000 | +69.2% | 5,000 | 0.0% | 0.01% | +40.0% |
| Q1 2017 | $26,000 | +73.3% | 5,000 | 0.0% | 0.01% | +66.7% |
| Q4 2016 | $15,000 | -34.8% | 5,000 | 0.0% | 0.00% | -25.0% |
| Q3 2016 | $23,000 | -20.7% | 5,000 | 0.0% | 0.00% | -33.3% |
| Q2 2016 | $29,000 | -3.3% | 5,000 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $30,000 | -34.8% | 5,000 | 0.0% | 0.01% | -33.3% |
| Q4 2015 | $46,000 | +64.3% | 5,000 | 0.0% | 0.01% | +50.0% |
| Q3 2015 | $28,000 | -49.1% | 5,000 | 0.0% | 0.01% | -40.0% |
| Q2 2015 | $55,000 | -29.5% | 5,000 | 0.0% | 0.01% | -33.3% |
| Q1 2015 | $78,000 | +2.6% | 5,000 | 0.0% | 0.02% | 0.0% |
| Q4 2014 | $76,000 | +40.7% | 5,000 | 0.0% | 0.02% | +25.0% |
| Q3 2014 | $54,000 | -28.9% | 5,000 | 0.0% | 0.01% | -29.4% |
| Q2 2014 | $76,000 | – | 5,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,400,000 | $12,320,000 | 4.56% |
| EcoR1 Capital, LLC | 2,568,119 | $22,599,000 | 4.01% |
| FIC CAPITAL INC | 960,338 | $8,451,000 | 3.48% |
| Opaleye Management Inc. | 580,000 | $5,104,000 | 2.13% |
| DAFNA Capital Management LLC | 225,000 | $1,980,000 | 1.41% |
| RA Capital Management | 1,250,000 | $11,000,000 | 1.26% |
| Iguana Healthcare Management, LLC | 215,000 | $1,892,000 | 1.07% |
| Avoro Capital Advisors LLC | 800,000 | $7,040,000 | 0.89% |
| WASATCH ADVISORS LP | 6,930,535 | $60,989,000 | 0.85% |
| Cormorant Asset Management, LP | 400,000 | $3,520,000 | 0.58% |